|
| InsiderPie Expert Score
| P/E ratio
| Net margin
| ROA
| Net income per employee
|
| Takeda Pharmaceutical Company Limited
|
54
/ 100
| 51
| 3.1%
| 1.0%
| €16.05K
|
| Deciphera Pharmaceuticals, Inc.
|
50
/ 100
| -12
| -108.9%
| -45.2%
| -€457.51K
|
| PolyPeptide Group AG
|
50
/ 100
| -16
| -7.3%
| -6.3%
| -€32.07K
|
| Dermapharm Holding SE
|
51
/ 100
| 17
| 9.1%
| 5.0%
| €29.70K
|
| Neurocrine Biosciences, Inc.
|
56
/ 100
| 36
| 13.9%
| 9.0%
| €165.05K
|
| Supernus Pharmaceuticals, Inc.
|
48
/ 100
| 27
| 9.7%
| 4.7%
| €81.62K
|
| Ironwood Pharmaceuticals, Inc.
|
50
/ 100
| -17
| -2.3%
| -2.0%
| -€23.44K
|
| Lifecore Biomedical, Inc.
|
48
/ 100
| -7.8
| -30.0%
| -16.2%
| -€63.02K
|
| AB Science S.A.
|
50
/ 100
| -4.2
| -970.4%
| -85.5%
| -€495.40K
|
| Zoetis Inc.
|
65
/ 100
| 27
| 27.8%
| 18.0%
| €161.44K
|
| Shield Therapeutics plc
|
50
/ 100
| -0.72
| -134.9%
| -104.7%
| -€874.92K
|
| Swedencare AB (publ)
|
50
/ 100
| 103
| 2.5%
| 0.7%
| €9.89K
|
| Boiron SA
|
50
/ 100
| 8.9
| 4.8%
| 8.2%
| €19.10K
|
| Aytu BioPharma, Inc.
|
50
/ 100
| -0.96
| -20.4%
| -10.9%
| -€113.41K
|
| Apontis Pharma AG
|
56
/ 100
| -8.5
| -12.3%
| -23.8%
| -€77.00K
|
| Eagle Pharmaceuticals, Inc.
|
50
/ 100
| 2.4
| 6.0%
| 3.8%
| €99.08K
|
| Acorda Therapeutics, Inc.
|
50
/ 100
| -0.0031
| -227.8%
| -322.9%
| -€2.20M
|
| Shionogi & Co., Ltd.
|
50
/ 100
| 13
| 38.9%
| 11.1%
| €198.70K
|
| Dr. Reddy's Laboratories Limited
|
49
/ 100
| 19
| 17.0%
| 10.9%
| €20.71K
|
| ECO Animal Health Group plc
|
52
/ 100
| 15
| 1.6%
| 2.3%
| €13.82K
|
| Intra-Cellular Therapies, Inc.
|
45
/ 100
| -188
| -11.0%
| -5.5%
| -€74.06K
|
| Allergy Therapeutics plc
|
50
/ 100
| -4
| -78.8%
| -117.7%
| -€160.99K
|
| Amneal Pharmaceuticals, Inc.
|
46
/ 100
| 1.1K
| 0.1%
| 0.1%
| €346.83
|
| Evolus, Inc.
|
50
/ 100
| -9.5
| -22.3%
| -27.1%
| -€142.15K
|
| SCYNEXIS, Inc.
|
50
/ 100
| -1.4
| -599.0%
| -32.2%
| -€594.54K
|
| PLx Pharma Inc.
|
50
/ 100
| -0.17
| -333.3%
| -45.6%
| -€807.35K
|
| Fagron NV
|
50
/ 100
| 11
| 9.2%
| 13.9%
| €39.47K
|
| Almirall, S.A.
|
55
/ 100
| 107
| 2.0%
| 0.9%
| €10.53K
|
| Recro Pharma, Inc.
|
50
/ 100
| -13
| -14.0%
| -8.6%
| -€43.88K
|
| HUTCHMED (China) Limited
|
53
/ 100
| 70
| 6.0%
| 3.0%
| €17.77K
|
| Elanco Animal Health Incorporated
|
51
/ 100
| 16
| 9.7%
| 3.2%
| €41.13K
|
| Evotec SE
|
54
/ 100
| -8.1
| -20.0%
| -8.6%
| -€32.63K
|
| Siegfried Holding AG
|
50
/ 100
| 139
| 11.0%
| 14.4%
| €77.95K
|
| Mithra Pharmaceuticals SA
|
50
/ 100
| -0.062
| -217.6%
| -81.4%
| -€863.41K
|
| Collegium Pharmaceutical, Inc.
|
51
/ 100
| 27
| 5.1%
| 2.3%
| €86.66K
|
| Sumitomo Pharma Co., Ltd.
|
51
/ 100
| 15
| 5.9%
| 3.2%
| €27.41K
|
| MERCK Kommanditgesellschaft auf Aktien
|
54
/ 100
| 17
| 13.5%
| 6.0%
| €48.51K
|
| Lantheus Holdings, Inc.
|
52
/ 100
| 21
| 17.8%
| 12.8%
| €286.08K
|
| Ipsen S.A.
|
51
/ 100
| 8.6
| 14.8%
| 15.4%
| €184.83K
|
| Dynavax Technologies Corporation
|
54
/ 100
| -23
| -16.7%
| -5.7%
| -€111.06K
|
| Vetoquinol SA
|
51
/ 100
| 7.6
| 10.7%
| 15.4%
| €45.35K
|
| ANI Pharmaceuticals, Inc.
|
44
/ 100
| -129
| -1.5%
| -0.8%
| -€10.49K
|
| Viatris Inc.
|
50
/ 100
| -2.8
| -26.5%
| -9.9%
| -€101.02K
|
| Tilray Brands, Inc.
|
45
/ 100
| -1.7
| -30.0%
| -5.9%
| -€80.11K
|
| DURECT Corporation
|
51
/ 100
| -5.6
| 290.1%
| -27.9%
| -€141.26K
|
| CV Sciences, Inc.
|
50
/ 100
| -4.7
| -10.4%
| -19.5%
| -€28.17K
|
| Hikma Pharmaceuticals PLC
|
52
/ 100
| 9.3
| 10.5%
| 11.8%
| €58.90K
|
| Aerie Pharmaceuticals, Inc.
|
50
/ 100
| 0
| -17.1%
| -9.7%
| -€82.92K
|
| Trees Corporation
|
50
/ 100
| -0.36
| -41.7%
| -28.6%
| -€56.71K
|
| PetIQ, Inc.
|
50
/ 100
| 70
| 1.2%
| 1.5%
| €10.04K
|
| Sonoma Pharmaceuticals, Inc.
|
47
/ 100
| -1.3
| -23.8%
| -24.4%
| -€303.22K
|
| Eisai Co., Ltd.
|
53
/ 100
| 39
| 5.9%
| 3.3%
| €24.24K
|
| Alliance Pharma plc
|
50
/ 100
| -8
| -12.2%
| -11.9%
| -€173.56K
|
| Organogenesis Holdings Inc.
|
50
/ 100
| -42
| -2.6%
| -2.4%
| -€10.78K
|
| Esperion Therapeutics, Inc.
|
50
/ 100
| -2
| -35.8%
| -27.1%
| -€269.60K
|
| Sandoz Group AG
|
48
/ 100
| 75
| 1.9%
| 1.4%
| €12.01K
|
| Teva Pharmaceutical Industries Limited
|
62
/ 100
| -122
| -1.0%
| -0.4%
| -€3.64K
|
| Emergent BioSolutions Inc.
|
49
/ 100
| 2.5
| 16.5%
| 9.8%
| €132.21K
|
| China Shineway Pharmaceutical Group Limited
|
50
/ 100
| 0.15
| 20.0%
| 17.7%
| €62.53K
|
| Amphastar Pharmaceuticals, Inc.
|
51
/ 100
| 8.1
| 18.7%
| 8.3%
| €56.66K
|
| Cosmos Health Inc.
|
50
/ 100
| -0.81
| -27.9%
| -24.9%
| -€88.00K
|
| Biostar Pharmaceuticals, Inc.
|
50
/ 100
| 0.00028
| 294.2%
| 2.3%
| €3.99K
|
| Guardion Health Sciences, Inc.
|
50
/ 100
| 0.68
| 68.2%
| 41.7%
| €604.17K
|
| Swedish Orphan Biovitrum AB (publ)
|
51
/ 100
| 22
| 16.2%
| 6.4%
| €206.61K
|
